Osteoimmunology: Cytokines and the skeletal system

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 7, 2008, Pages 495-510

  Lee, Seoung Hoon ^a   Kim, Tae Soo ^a   Choi, Yongwon ^a   Lorenzo, Joseph ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Immune system; Osteoblast; Osteoclast; Osteoimmunology

Indexed keywords

EID: 49149107848     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.7.495     Document Type: Short Survey

References (204)

1. Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J. and Choi, Y. (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24, 33-63.
2. Takayanagi, H. (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304.
3. Arron, J. R. and Choi, Y. (2000) Bone versus immune system. Nature 408, 535-536.
4. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
5. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J.(1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
6. Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M. and Suda, T. (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J. Exp. Med. 190, 1741-1754.
7. Jacquin, C., Gran, D. E., Lee, S. K., Lorenzo, J. A. and Aguila, H. L. (2006) Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Min. Res. 21, 67-77.
8. Miyamoto, T., Ohneda, O., Arai, F., Iwamoto, K., Okada, S., Takagi, K., Anderson, D. M. and Suda, T. (2001) Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98, 2544-2554.
9. Alnaeeli, M., Penninger, J. M. and Teng, Y. T. (2006) Immune Interactions with CD4+ T Cells Promote the Development of Functional Osteoclasts from Murine CD11c+ Dendritic Cells. J. Immunol. 177, 3314-3326.
10. Speziani, C., Rivollier, A., Gallois, A., Coury, F., Mazzorana, M., Azocar, O., Flacher, M., Bella, C., Tebib, J., Jurdic, P., Rabourdin-Combe, C. and Delprat , C. (2007) Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur. J. Immunol. 37, 747-757.
11. Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A. and Geissmann, F. (2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87.
12. Mochizuki, A., Takami, M., Kawawa, T., Suzumoto, R., Sasaki, T., Shiba, A., Tsukasaki, H., Zhao, B., Yasuhara, R., Suzawa, T., Miyamoto , Y., Choi, Y. and Kamijo, R. (2006) Identification and characterization of the precursors committed to osteoclasts induced by TNF related activation-induced cytokine/receptor activator of NF-kappa B ligand. J. Immunol. 177, 4360-4368.
13. Li, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Looney, R. J., Ritchlin, C. T., Boyce, B. F. and Xing, L. (2004) Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 50, 265-276.
14. Yao, Z., Li, P., Zhang, Q., Schwarz, E. M., Keng, P., Arbini, A., Boyce, B. F. and Xing, L. (2006) Tnf increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through upregulation of c-fms expression. J. Biol. Chem. 281, 11846-11855.
15. Atkins, G. J., Kostakis, P., Vincent, C., Farrugia, A. N., Houchins, J. P., Findlay, D. M., Evdokiou, A. and Zannettino, A. C. (2006) RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J. Bone. Min. Res. 21, 1339-1349.
16. Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K. and Miyasaka, N. (2006) Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res.Ther. 8, R152.
17. Sorensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H. and Karsdal, M. A. (2007) Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J. Bone Min. Res. 25, 36-45.
18. Kindle, L., Rothe, L., Kriss, M., Osdoby, P. and Collin-Osdoby, P. (2006) Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J. Bone Min. Res. 21, 193-206.
19. Miyamoto, T., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M. and Suda, T. (2000) An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 96, 4335-4343.
20. Mocsai, A., Humphrey, M. B., Van Ziffle, J. A., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A. and Nakamura, M. C. (2004) The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. U. S. A. 101, 6158-6163.
21. Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., Taniguchi , T., Takayanagi, H. and Takai , T. (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763.
22. Aubin, J. E. (2001) Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2, 81-94.
23. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
24. Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V., Wang, E. A. and Wozney, J. M. (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. U. S. A. 87, 9843-9847.
25. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R. and de Crombrugghe, B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
26. Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D. and MacDougald, O. A. (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102, 3324-3329.
27. Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W. N., Allgrove, J., Arslan-Kirchner, M., Batch, J. A., Beighton, P., Black, G. C., Boles, R. G., Boon, L. M., Borrone, C., Brunner, H. G., Carle, G. F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M. L., Hall, B., Hennekam, R. C., Hirose, T., Jans, A., Jüppner, H., Kim, C. A., Keppler-Noreuil, K., Kohlschuetter, A., LaCombe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R. S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., van den Boogaard, M. J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B. R., Warman, M. L.; Osteoporosis-Pseudoglioma Syndrome Collaborative Group. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523.
28. Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H., Glass, D. A. 2nd, Hartmann, C., Li, L., Hwang, T. H., Brayton, C. F., Lang, R. A., Karsenty, G. and Chan, L. (2002) Cbfa1- independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell. Biol. 157, 303-314.
29. Wei, S., Kitaura, H., Zhou, P., Ross, F. P. and Teitelbaum, S. L. (2005) IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282-290.
30. Kitaura, H., Zhou, P., Kim, H. J., Novack, D. V., Ross, F. P. and Teitelbaum, S. L. (2005) M-CSF mediates TNF-induced inflammatory osteolysis. J. Clin. Invest. 115, 3418-3427.
31. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T. J. and Suda, T. (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191, 275-286.
32. Li, J., Sarosi, I., Yan, X. Q., Morony, S., Capparelli, C., Tan, H. L., McCabe, S., Elliott, R., Scully, S., Van, G., Kaufman, S., Juan S. C., Sun, Y., Tarpley, J., Martin, L., Christensen, K., McCabe, J., Kostenuik, P., Hsu, H., Fletcher, F., Dunstan, C. R., Lacey, D. L. and Boyle, W. J. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97, 1566-1571.
33. Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J. and Nanes, M. S. (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141, 3956.
34. Centrella, M., McCarthy, T. L. and Canalis, E. (1988) Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123, 1442-1448.
35. Smith, D. D., Gowen, M., and Mundy, G. R. (1987) Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120, 2494-2499.
36. Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M. and Manolagas, S. C. (1998) Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 13, 793-802.
37. Kawakami, A., Eguchi, K., Matsuoka, N., Tsuboi, M., Koji, T., Urayama, S., Fujiyama, K., Kiriyama, T., Nakashima, T., Nakane, P.K. and Nagataki, S. (1997) Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J. Bone Miner. Res. 12, 1637-1647.
38. Park, H., Jung, Y. K., Park, O. J., Lee, Y. J., Choi, J. Y. and Choi, Y. (2005) Interaction of fas ligand and fas expressed on osteoclast precursors increases osteoclastogenesis. J. Immunol. 175, 7193-7201.
39. Wu, X., McKenna, M. A., Feng, X., Nagy, T. R. and McDonald, J. M. (2003) Osteoclast Apoptosis: The role of Fas in vivo and in vitro. Endocrinology 144, 5545-5555.
40. Wu, X., Pan, G., McKenna, M. A., Zayzafoon, M., Xiong, W. C. and McDonald, J. M. (2005) RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. J. Bone Min. Res. 20, 107-116.
41. Katavic, V., Lukic, I. K., Kovacic, N., Grcevic, D., Lorenzo, J. A. and Marusic, A. (2003) Increased Bone Mass Is a Part of the Generalized Lymphoproliferative Disorder pheno type in the mouse. J. Immunol. 170, 1540-1547.
42. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P. and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823.
43. Roux, S., Lambert-Comeau, P., Saint-Pierre, C., Lepine, M., Sawan, B. and Parent, J. L. (2005) Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem. Biophys. Res. Commun. 333, 42-50.
44. Zauli, G., Rimondi, E., Stea, S., Baruffaldi, F., Stebel, M., Zerbinati, C., Corallini, F. and Secchiero, P. (2008) TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27(Kip1) accumulation in pre-osteoclast precursors. J. Cell Physiol. 214, 117-125
45. Tinhofer, I., Biedermann, R., Krismer, M., Crazzolara, R. and Greil, R. (2006) A role of TRAIL in killing osteoblasts by myeloma cells. FASEB J. 20, 759-761.
46. Lopez-Granados, E., Temmerman, S. T., Wu, L., Reynolds, J. C., Follmann, D., Liu, S., Nelson, D. L., Rauch, F. and Jain, A. (2007) Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc. Natl. Acad. Sci. U. S. A. 104, 5056-5061.
47. Lee, H. Y., Jeon, H. S., Song, E. K., Han, M. K., Park, S. I., Lee, S. I., Yun, H. J., Kim, J. R., Kim, J. S., Lee, Y. C., Kim, S. I., Kim, H. R., Choi, J. Y., Kang, I., Kim, H. Y. and Yoo, W. H. (2006) CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-medicated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis. Rheum. 54, 1747-1758.
48. Rubin, J., Fan, X., Thornton, D., Bryant, R. and Biskobing, D. (1996) Regulation of murine osteoblast macrophage colony-stimulating factor production by 1, 25(OH)2D3. Calcif. Tissue Int. 59, 291-296.
49. Weir, E. C., Horowitz, M. C., Baron, R., Centrella, M., Kacinski, B. M. and Insogna, K. L. (1993) Macrophage colony-stimulating factor release and receptor expression in bone cells. J. Bone Miner. Res. 8, 1507-1518.
50. Yao, G. Q., Sun, B. H., Hammond, E. E., Spencer, E. N., Horowitz, M. C., Insogna, K. L. and Weir, E. C. (1998) The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J. Biol. Chem. 273, 4119-4128.
51. Shinar, D. M., Sato, M. and Rodan, G. A. (1990) The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. Endocrinology 126, 1728-1735.
52. Fuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R. and Chambers, T. J. (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 178, 1733-1744.
53. Lagasse, E. and Weissman, I. L. (1997) Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89, 1021-1031.
54. Lorenzo, J. A., Sousa, S. L., Fonseca, J. M., Hock, J. M. and Medlock, E. S. (1987) Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J. Clin. Invest. 80, 160-164.
55. Khapli, S. M., Mangashetti, L. S., Yogesha, S. D. and Wani, M. R. (2003) IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-kappaB Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage. J. Immunol. 171, 142-151.
56. Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J. and Gillespie, M. T. (1997) Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J. Exp. Med. 185, 1005-1012.
57. Takahashi, N., Udagawa, N., Akatsu, T., Tanaka, H., Shionome, M. and Suda, T. (1991) Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6, 97785.
58. Yogesha, S. D., Khapli, S. M. and Wani, M. R. (2005) Interleukin-3 and granulocyte-macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-alpha-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2. J. Biol. Chem. 280, 11759-11769.
59. Ehrlich, L. A., Chung, H. Y., Ghobrial, I., Choi, S. J., Morandi, F., Colla, S., Rizzoli, V., Roodman, G. D. and Giuliani, N. (2005) IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood 106, 1407-1414.
60. Soshi, S., Takahashi, H. E., Tanizawa, T., Endo, N., Fujimoto, R. and Murota, K. (1996) Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on rat bone: inhibition of bone formation at the endosteal surface of vertebra and tibia. Calcif. Tissue Int. 58, 337-340.
61. Takamatsu, Y., Simmons, P. J., Moore, R. J., Morris, H. A., To, L. B. and Levesque, J. P. (1998) Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 92, 3465-3473.
62. Lapidot, T. and Petit, I. (2002) Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30, 973-981.
63. Purton, L. E., Lee, M. Y. and Torok-Storb, B. (1996) Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 87, 1802-1808.
64. Kuwabara, H., Wada, T., Oda, T., Yoshikawa, H., Sawada, N., Kokai, Y. and Ishii, S. (2001) Overexpression of the granulocyte colony-stimulating factor gene impairs bone morphogenetic protein responsiveness in mice. Lab Invest. 81, 1133-1141.
65. Oda, T., Wada, T., Kuwabara, H., Sawada, N., Yamashita, T. and Kokai, Y. (2005) Ovariectomy fails to augment bone resorption and marrow B lymphopoiesis in granulocyte colony-stimulating factor transgenic mice. J. Orthop. Sci. 10, 70-76.
66. Lee, S. K., Gardner, A. E., Kalinowski, J. F., Jastrzebski, S. L. and Lorenzo, J. A. (2005) RANKL-stimulated osteoclastlike cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 38, 678-685.
67. Lee, S. K., Kalinowski, J., Jastrzebski, S. and Lorenzo, J. A. (2002) 1, 25 (OH)(2) vitamin D(3)-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1alpha and receptor activator of NF-kappa B ligand production in osteoblasts. J. Immunol. 169, 2374-2380.
68. Lorenzo, J. A., Sousa, S., Alander, C., Raisz, L. G. and Dinarello, C. A. (1987) Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121, 1164-1170.
69. Sato, K., Fujii, Y., Asano, S., Ohtsuki, T., Kawakami, M., Kasono, K., Tsushima, T. and Shizume, K. (1986) Recombinant human interleukin 1 alpha and beta stimulate mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2. Biochem. Biophy. Res. Comm. 141, 285-291.
70. Klein, D. C. and Raisz, L. G. (1970) Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86, 1436-1440.
71. Ma, T., Miyanishi, K., Suen, A., Epstein, N. J., Tomita, T., Smith, R.L. and Goodman, S. B. (2004) Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Cytokine 26, 138-144.
72. Sato, N., Takahashi, N., Suda, K., Nakamura, M., Yamaki, M., Ninomiya, T., Kobayashi, Y., Takada, H., Shibata, K., Yamamoto, M., Takeda, K., Akira, S., Noguchi, T. and Udagawa, N. (2004) MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J. Exp. Med. 200, 601-611.
73. Lee, Z. H., Lee, S. E., Kim, C. W., Lee, S. H., Kim, S. W., Kwack, K., Walsh, K. and Kim, H. H. (2002) IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways. J. Biochem. 131, 161-166.
74. Bajayo, A., Goshen, I., Feldman, S., Csernus, V., Iverfeldt, K., Shohami, E., Yirmiya, R. and Bab, I. (2005) Central IL-1 receptor signaling regulates bone growth and mass. Proc. Natl. Acad. Sci. U. S. A. 102, 12956-12961.
75. Vargas, S. J., Naprta, A., Glaccum, M., Lee, S. K., Kalinowski, J. and Lorenzo, J. A. (1996) Interleukin-6 expression and histomorphometry of bones from mice deficient for receptors for interleukin-1 or tumor necrosis factor. J. Bone Min. Res. 11, 1736-1740.
76. Lowik, C. W., Van der, P. G., Bloys, H., Hoekman, K., Bijvoet, O. L., Aarden, L. A. and Papapoulos, S. E. (1989) Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogeneis. Biochem. Biophys. Res. Commun. 162, 1546-1552.
77. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C. and Manolagas, S. C. (1992) 17á-Estradiol inhibits interleukin-6 production by bone marrow- derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89, 883-891.
78. Al-Humidan, A., Ralston, S. H., Hughes, D. E., Chapman, K., Aarden, L., Russell, R. G. G. and Gowen, M. (1991) Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J. Bone Min. Res. 6, 3-7.
79. Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., Kishimoto, T. and Suda, T. (1990) IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145, 3297-3303.
80. Manolagas, S. C. and Jilka, R. L. (1995) Mechanisms of disease: Bone marrow, cytokines, and bone remodeling-Emerging insights into the pathophysiology of osteoporosis. N. Eng. J. Med. 332, 305-311.
81. Liu, X. H., Kirschenbaum, A., Yao, S. and Levine, A. C. (2005) Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/ receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 146, 1991-1998.
82. Palmqvist, P., Persson, E., Conaway, H. H. and Lerner, U. H. (2002) IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-kappaB Ligand, Osteoprotegerin, and Receptor Activator of NF-kappaB in Mouse Calvariae. J. Immunol. 169, 3353-3362.
83. Whyte, M. P. and Mumm, S. (2004) Heritable disorders of the RANKL/OPG/RANK signaling pathway. J. Musculoskelet. Neuronal. Interact. 4, 254-267.
84. Guise, T. A. and Mundy, G. R. (1998) Cancer and bone. Endcr. Rev. 19, 18-54.
85. Yamamoto, T., Ozono, K., Kasayama, S., Yoh, K., Hiroshima, K., Takagi, M., Matsumoto, S., Michigami, T., Yamaoka, K., Kishimoto, T. and Okada, S. (1996) Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J. Clin. Invest. 98, 30-35.
86. Reddy, S. V., Takahashi, S., Dallas, M., Williams, R. E., Neckers, L. and Roodman, G. D. (1994) Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J. Bone Miner. Res. 9, 753-757.
87. Devlin, R. D., Bone, H. G., III and Roodman, G. D. (1996) Interleukin-6: A potential mediator of the massive osteolysis in patientswith Gorham-Stout disease. J. Clin. Endocrinol. Metab. 81, 1893-1897.
88. Grey, A., Mitnick, M. A., Masiukiewicz, U., Sun, B. H., Rudikoff, S., Jilka, R. L., Manolagas, S. C. and Insogna, K. (1999) A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140, 4683-4690.
89. O'Brien, C. A., Jilka, R.L., Fu, Q., Stewart, S., Weinstein, R. S. and Manolagas, S. C. (2005) IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab. 289, E784-793.
90. Elias, J. A., Tang, W. and Horowitz, M. C. (1995) Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136, 489-498.
91. Girasole, G., Passeri, G., Jilka, R. L. and Manolagas, S. C. (1994) Interleukin-11: A new cytokine critical for osteoclast development. J. Clin. Invest. 93, 1516-1524.
92. Hill, P. A., Tumber, A., Papaioannou, S. and Meikle, M. C. (1998) The cellular actions of interleukin-11 on bone resorption in vitro. Endocrinology 139, 1564-1572.
93. Morinaga, Y., Fujita, N., Ohishi, K., Zhang, Y. and Tsuruo, T. (1998) Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors. J. Cell Physiol. 175, 247-254.
94. Sims, N. A., Jenkins, B. J., Nakamura, A., Quinn, J. M., Li, R., Gillespie, M. T., Ernst, M., Robb, L. and Martin, T. J. (2005) Interleukin-11 receptor signaling is required for normal bone remodeling. J. Bone Min. Res. 20, 1093-1102.
95. Greenfield, E. M., Horowitz, M. C. and Lavish, S. A. (1996) Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J. Biol. Chem. 271, 10984-10989.
96. Reid, I. R., Lowe, C., Cornish, J., Skinner, S. J., Hilton, D. J., Willson, T. A., Gearing, D. P. and Martin, T. J. (1990) Leukemia inhibitory factor: a novel bone-active cytokine. Endocinology 126, 1416-1420.
97. Lorenzo, J. A., Sousa, S. L. and Leahy, C. L. (1990) Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures. Cytokine. 2, 266-271.
98. Van Beek, E., Van der Wee-Pals, L., van de Ruit, M., Nijweide, P., Papapoulos, S. and Lowik, C. (1993) Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture. J. Bone Min. Res. 8, 191-198.
99. Cornish, J., Callon, K., King, A., Edgar, S. and Reid, I. R. (1993) The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 132, 1359-1366.
100. Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., Cheng, L., Donovan, P. J., Peschon, J. J., Bartlett, P. F., Willis, C. R., Wright, B. D., Carpenter, M. K., Davison, B. L., and Gearing, D. P. (1995) Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121, 1283-1299.
101. Heymann, D., Guicheux, J., Gouin, F., Cottrel, M. and Daculsi, G. (1998) Oncostatin M stimulates macrophage-polykaryon formation in long-term human bone-marrow cultures. Cytokine. 10, 98-109.
102. Jay, P. R., Centrella, M., Lorenzo, J., Bruce, A. G. and Horowitz, M. C. (1996) Oncostatin-M: A new bone active cytokine that activates osteoblasts and inhibits bone resorption. Endocrinology 137, 1151-1158.
103. Malik, N., Haugen, H. S., Modrell, B., Shoyab, M. and Clegg, C. H. (1995) Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol. Cell. Biol. 15, 2349-2358.
104. Kawasaki, K., Gao, Y. H., Yokose, S., Kaji, Y., Nakamura, T., Suda, T., Yoshida, K., Taga, T., Kishimoto, T., Kataoka, H., Yuasa, T., Norimatsu, H. and Yamaguchi, A. (1997) Osteoclasts are present in gp130-deficient mice. Endocrinology 138, 4959-4965.
105. Weitzmann, M. N., Roggia, C., Toraldo, G., Weitzmann, L. and Pacifici, R. (2002) Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 110, 1643-1650.
106. Weitzmann, M. N., Cenci, S., Rifas, L., Brown, C. and Pacifici, R. (2000) Interleukin-7 stimulates osteoclast formation by up-regulating the T- cell production of soluble osteoclastogenic cytokines. Blood 96, 1873-1878.
107. Toraldo, G., Roggia, C., Qian, W. P., Pacifici, R. and Weitzmann, M. N. (2003) IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U. S. A. 100, 125-130.
108. Ryan, M. R., Shepherd, R., Leavey, J. K., Gao, Y. H., Grassi, F., Schnell, F. J., Qian, W. P., Kersh, G. J., Weitzmann, M. N. and Pacifici, R. (2005) An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. U. S. A. 102, 16735-16740.
109. Lee, S. K., Kalinowski, J. F., Jastrzebski, S. L., Puddington, L. and Lorenzo, J. A. (2003) Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 144, 524-3531.
110. Lee, S. K., Kalinowski, J. F., Jacquin, C., Adams, D. J., Gronowicz, G. and Lorenzo, J. A. (2006) Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J. Bone Miner. Res. 21, 695-702.
111. Sato, T., Watanabe, K., Masuhara, M., Hada, N. and Hakeda, Y. (2007) Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J. Bone Miner. Res. 25, 19-27.
112. Lee, S., Kalinowski, J. F., Adams, D. J., Aguila, H. L. and Lorenzo, J. A. (2004) Osteoblast specific overexpression of human interleukin-7 increases femoral trabecular bone mass in female mice and inhibits in vitro osteoclastogenesis. J. Bone Miner. Res. 19, S410.
113. Lee, S., Kalinowski J, Adams D. J, Aguila H. L. and Lorenzo, J. A. (2005) Osteoblast specific overexpression of human interlukin-7 rescues the bone phenotype of interleukin-7 deficient female mice. J. Bone Miner. Res. 20, S48.
114. Campbell, J. J. and Butcher, E. C. (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 121, 336-341.
115. Bendre, M. S., Margulies, A. G., Walser, B., Akel, N. S., Bhattacharrya, S., Skinner, R. A., Swain, F., Ramani, V., Mohammad, K. S., Wessner, L. L., Martinez, A., Guise, T. A., Chirgwin, J. M., Gaddy, D. and Suva, L. J. (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res. 65, 11001-11009.
116. Bendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D. and Suva, L. J. (2003) Interleukin-8 stim ulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33, 28-37.
117. Sunyer, T., Rothe, L., Jiang, X. S., Osdoby, P. and Collin-Osdoby, P. (1996) Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J. Cell Biochem. 60, 469-483.
118. Choi, J., Oba, Y., Jelinek, D., Ehrlich, L., Lee, W. and Roodman, D. (2003) Blocking CCR1 or CCR5 inhibits both osteoclast formation and increased alpha1-integrin expression induced by MIP-1alpha. Eur. J. Haematol. 70, 272-278.
119. Kukita, T., Nomiyama, H., Ohmoto, Y., Kukita, A., Shuto, T., Hotokebuchi, T., Sugioka, Y., Miura, R. and Iijima, T. (1997) Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment. Lab. Invest. 76, 399-406.
120. Watanabe, T., Kukita, T., Kukita, A., Wada, N., Toh, K., Nagata, K., Nomiyama, H. and Iijima, T. (2004) Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J. Endocrinol. 180, 193-201.
121. Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D. and Matsumoto, T. (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 100, 2195-2202.
122. Choi, S. J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J. and Roodman, G. D. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J. Clin. Invest. 108, 1833-1841.
123. Fuller, K., Owens, J. M. and Chambers, T. J. (1995) Macrophage inflammatory protein-1à and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J. Immunol. 154, 6065-6072.
124. Okamatsu, Y., Kim, D., Battaglino, R., Sasaki, H., Spate, U. and Stashenko, P. (2004) MIP-1{gamma} Promotes Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Formation and Survival. J. Immunol. 173, 2084-2090.
125. Yu, X., Huang, Y., Collin-Osdoby, P. and Osdoby, P. (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J. Bone Min. Res. 19, 2065-2077.
126. Lean, J. M., Murphy, C., Fuller, K. and Chambers, T. J. (2002) CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87, 386-393.
127. Yang, M., Mailhot, G., MacKay, C. A., Mason-Savas, A., Aubin, J. and Odgren, P. R. (2006) Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. Blood 107, 2262-2270.
128. Ishida, N., Hayashi, K., Hattori, A., Yogo, K., Kimura, T. and Takeya, T. (2006) CCR1 Acts Downstream of NFAT2 in Osteoclastogenesis and Enhances Cell Migration. J. Bone Min. Res. 21, 48-57.
129. Wright, L. M., Maloney, W., Yu, X., Kindle, L., Collin-Osdoby, P. and Osdoby, P. (2005) Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36, 840-853.
130. Grassi, F., Piacentini, A., Cristino, S., Toneguzzi, S., Cavallo, C., Facchini, A. and Lisignoli, G. (2003) Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem. Cell. Biol. 120, 391-400.
131. Liao, T. S., Yurgelun, M. B., Chang, S. S., Zhang, H. Z., Murakami, K., Blaine, T. A., Parisien, M. V., Kim, W., Winchester, R. J. and Lee, F. Y. (2005) Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J. Orthop. Res. 23, 203-209.
132. Zannettino, A. C., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., Diamond, P., Tamamura, H., Lapidot, T., Fujii, N. and Gronthos, S. (2005) Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in
133. Rahimi, P., Wang, C., Stashenko, P., Lee, S. K., Lorenzo, J. A. and Graves, D. T. (1995) Monocyte chemoattractant protein-1 Expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology 136, 2752-2759.
134. Zhu, J. F., Valente, A. J., Lorenzo, J. A., Carnes, D. and Graves, D. T. (1994) Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J. Bone Min. Res. 9, 1123-1130.
135. Wise, G. E., Huang, H. and Que, B. G. (1999) Gene expression of potential tooth eruption molecules in the dental follicle of the mouse. Eur. J. Oral. Sci. 107, 482-486.
136. Graves, D. T., Alsulaimani, F., Ding, Y. and Marks, S. C., Jr. (2002) Developmentally regulated monocyte recruitment and bone resorption are modulated by functional deletion of the monocytic chemoattractant protein-1 gene. Bone 31, 282-287.
137. Kim, M. S., Day, C. J. and Morrison, N. A. (2005) MCP-1 is induced by RANKL, promotes osteoclast fusion and rescues GM-CSF suppression of osteoclast formation. J. Biol. Chem. 280, 16163-16169.
138. Li, X., Qin, L., Bergenstock, M., Bevelock, L.M., Novack, D.V., and Partridge, N.C. (2007) Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J. Biol. Chem. 282, 33098-33106.
139. Owens, J. M., Gallagher, A. C. and Chambers, T. J. (1996) IL-1O modulates formation of osteoclasts in murine hemopoietic cultures. J. Immunol. 157, 936-940.
140. Hong, M. H., Williams, H., Jin, C. H. and Pike, J. W. (2000) The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins. J. Bone Min. Res. 15, 911-918.
141. Van Vlasselaer, P., Borremans, B., Van Der Heuvel, R., Van Gorp, U. and De Waal Malefyt, R. (1993) Interleukin-10 inhibits the osteogenic activity of mouse bone marrow. Blood 82, 2361-2370.
142. Evans, K. E. and Fox, S. W. (2007) Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell. Biol. 19, 4.
143. Mohamed, S. G., Sugiyama, E., Shinoda, K., Taki, H., Hounoki, H., bdel-Aziz, H. O., Maruyama, M., Kobayashi, M., Ogawa, H. and Miyahara, T. (2007) Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Bone. 41, 592-602.
144. Carmody, E. E., Schwarz, E. M., Puzas, J. E., Rosier, R. N. and O'Keefe, R. J. (2002) Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis. Rheum. 46, 1298-1308.
145. Liu, D., Yao, S. and Wise, G. E. (2006) Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle. Eur. J. Oral. Sci. 114, 42-49.
146. Shin, H. H., Lee, J. E., Lee, E. A., Kwon, B. S. and Choi, H. S. (2006) Enhanced Osteoclastogenesis in 4-1BB-Deficient Mice Caused by Reduced Interleukin-10. J. Bone Min. Res. 21, 1907-1912.
147. Amcheslavsky, A. and Bar-Shavit, Z. (2006) Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J. Cell. Physiol. 207, 244-250.
148. Horwood, N. J., Elliott, J., Martin, T. J. and Gillespie, M. T. (2001) IL-12 Alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J. Immunol. 166, 4915-4921.
149. Nagata, N., Kitaura, H., Yoshida, N. and Nakayama, K. (2003) Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. Bone 33, 721-732.
150. Ogata, Y., Kukita, A., Kukita, T., Komine, M., Miyahara, A., Miyazaki, S. and Kohashi, O. (1999) A Novel Role of IL-15 in the Development of Osteoclasts: Inability to replace its activity with IL-2. J. Immunol. 162, 2754-2760.
151. Miranda-Carus, M. E., ito-Miguel, M., Balsa, A., Cobo-Ibanez, T., Perez De, A. C., Pascual-Salcedo, D. and Martin-Mola, E. (2006) Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis. Rheum. 54, 1151-1164.
152. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852.
153. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y. and Cua, D. J., Takayanagi, H. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673-2682.
154. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M.T., Martin, T. J. and Suda, T. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345-1352.
155. Van bezooijen, R. L., Farih-Sips, H. C., Papapoulos, S. E. and Lowik, C. W. (1999) Interleukin-17: A new bone acting cytokine in vitro. J. Bone Min. Res. 14, 1513-1521.
156. Koenders, M. I., Lubberts, E., Oppers-Walgreen, B., Van Den, B. L., Helsen, M. M., Di Padova, F. E., Boots, A. M., Gram, H., Joosten, L. A. and Van den Berg, W. B. (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167, 141-149.
157. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
158. Yamamura, M., Kawashima, M., Taniai, M., Yamauchi, H., Tanimoto, T., Kurimoto, M., Morita, Y., Ohmoto, Y. and Makino, H. (2001) Interferon-gamma- inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis. Rheum. 44, 275-285.
159. Horwood, N. J., Udagawa, N., Elliott, J., Grail, D., Okamura, H., Kurimoto, M., Dunn, A. R., Martin, T. and Gillespie, M. T. (1998) Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J. Clin. Invest. 101, 595-603.
160. Cornish, J., Gillespie, M. T., Callon, K. E., Horwood, N. J., Moseley, J. M. and Reid, I. R. (2003) Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Endocrinology 144, 1194-1201.
161. Kawase, Y., Hoshino, T., Yokota, K., Kuzuhara, A., Nakamura, M., Maeda, Y., Nishiwaki, E., Zenmyo, M., Hiraoka, K., Aizawa, H. and Yoshino, K. (2003) Bone malformations in interleukin-18 transgenic mice. J. Bone Min. Res. 18, 975-983.
162. Yamada, N., Niwa, S., Tsujimura, T., Iwasaki, T., Sugihara, A., Futani, H., Hayashi, S., Okamura, H., Akedo, H. and Terada, N. (2002) Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30, 901-908.
163. Makiishi-Shimobayashi, C., Tsujimura, T., Iwasaki, T., Yamada, N., Sugihara, A., Okamura, H., Hayashi, S. S. and Terada, N. (2001) Interleukin-18 Up-Regulates Osteoprotegerin Expression in Stromal/Osteoblastic Cells. Biochem. Biophy. Res. Comm. 281, 361-366.
164. Dai, S. M., Nishioka, K. and Yudoh, K. (2004) Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann. Rheum. Dis. 63, 1379-1386.
165. Gowen, M., and Mundy, G. R. (1986) Actions of recombinant interleukin 1, interleukin 2, and interferongamma on bone resorption in vitro. J. Immunol. 136, 2478-2482.
166. Takahashi, N., Mundy, G. R. and Roodman, G. D. (1986) Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J. Immunol. 137, 3544-3549.
167. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K. and Taniguchi, T. (2000) T-cell- mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605.
168. Hattersley, G., Dorey, E., Horton, M. A. and Chambers, T. J. (1988) Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J. Cell. Physiol. 137, 199-203.
169. Gao, Y., Grassi, F., Ryan, M. R., Terauchi, M., Page, K., Yang, X., Weitzmann, M. N. and Pacifici, R. (2007) IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117, 122-132.
170. Gowen, M., MacDonald, B. R. and Russell, G. G. (1988) Actions of recombinant human gamma-interferon and tumor necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis. Rheum. 31, 1500-1507.
171. Mann, G. N., Jacobs, T. W., Buchinsky, F. J., Armstrong, E. C., Li, M., Ke, H. Z., Ma, Y. F., Jee, W. S. S. and Epstein, S. (1994) Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology 135, 1077-1083.
172. Key, L. L., Jr., Rodriguiz, R. M., Willi, S. M., Wright, N. M., Hatcher, H. C., Eyre, D. R., Cure, J. K., Griffin, P. P. and Ries, W. L. (1995) Long-term treatment of osteopetrosis with recombinant human interferon gamma. N. Eng. J. Med. 332, 1594-1599.
173. Vignery, A., Niven-Fairchild, T. and Shepard, M. H. (1990) Recombinant murine interferon-gamma inhibits the fusion of mouse alveolar macrophages in vitro but stimulates the formation of osteoclast-like cells on implanted syngenic bone particles in mice in vivo. J. Bone Min. Res. 5, 637-644.
174. Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., Wagner, E. F. and Taniguchi, T. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416, 744-749.
175. Fox, S. W., Haque, S. J., Lovibond, A. C. and Chambers, T. J. (2003) The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J. Immunol. 170, 3679-3687.
176. Hayashi, T., Kaneda, T., Toyama, Y., Kumegawa, M. and Hakeda, Y. (2002) Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation. J. Biol. Chem. 277, 27880-27886.
177. Avnet, S., Cenni, E., Perut, F., Granchi, D., Brandi, M. L., Giunti, A. and Baldini, N. (2007) Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis. Int. J. Oncol. 30, 469-476.
178. Goodman, G. R., Dissanayake, I. R., Gorodetsky, E., Zhou, H., Ma, Y. F., Jee, W. S. and Epstein, S. (1999) Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat. Bone 25, 459-463.
179. Lewis, D. B., Liggitt, H. D., Effmann, E. L., Motley, S. T., Teitelbaum, S. L., Jepsen, K. J., Goldstein, S. A., Bonadio, J., Carpenter, J. and Perlmutter, R. M. (1993) Osteoporosis induced in mice by overproduction of interleukin 4. Proc. Natl. Acad. Sci. U. S. A. 90, 11618-11622.
180. Shioi, A., Teitelbaum, S. L., Ross, F. P., Welgus, H. G., Suzuki, H., Ohara, J. and Lacey, D. L. (1991) Interleukin 4 inhibits murine osteoclast formation in vitro. J. Cell. Biochem. 47, 272-277.
181. Okada, Y., Morimoto, I., Ura, K., Nakano, Y., Tanaka, Y., Nishida, S., Nakamura, T. and Eto, S. (1998) Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice. Bone 22, 361-365.
182. Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q.R., Seo, H., Ohta, H., Nozawa, S., Kudo, I. and Suda, T. (1996) IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase- 2-dependent prostaglandin synthesis in osteoblasts. J. Immunol. 156, 758-764.
183. Lind, M., Deleuran, B., Yssel, H., Fink-Eriksen, E. and Thestrup-Pedersen, K. (1995) IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 7, 78-82.
184. Palmqvist, P., Lundberg, P., Persson, E., Johansson, A., Lundgren, I., Lie, A., Conaway, H. H. and Lerner, U. H. (2006) Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. J. Biol. Chem. 281, 2414-2429.
185. Bendixen, A. C., Shevde, N. K., Dienger, K. M., Willson, T. M., Funk, C. D. and Pike, J. W. (2001) IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. U. S. A. 98, 2443-2448.
186. Kamel Mohamed, S. G., Sugiyama, E., Shinoda, K., Hounoki, H., Taki, H., Maruyama, M., Miyahara, T. and Kobayashi, M. (2005) Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: A possible mechanism for downregulation of osteoclastogenesis. Biochem. Biophy. Res. Comm. 329, 839-845.
187. Mangashetti, L. S., Khapli, S. M. and Wani, M. R. (2005) IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling. J. Immunol. 175, 917-925.
188. Moreno, J. L., Kaczmareck, M., Keegan, A. D. and Tondravi, M. (2003) IL-4 suppresses both osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102, 1078-1086.
189. Yamada, A., Takami, M., Kawawa, T., Yasuhara, R., Zhao, B., Mochizuki, A., Miyamoto, Y., Eto, T., Yasuda, H., Nakamichi, Y., Kim, N., Katagiri, T., Suda, T. and Kamijo, R. (2007) Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology 120, 573-579.
190. Baugh, J. A. and Bucala, R. (2002) Macrophage migration inhibitory factor. Crit. Care Med. 30, S27-S35.
191. Onodera, S., Sasaki, S., Ohshima, S., Amizuka, N., Li, M., Udagawa, N., Irie, K., Nishihira, J., Koyama, Y., Shiraishi, A., Tohyama, H. and Yasudam, K. (2006) Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis. J. Bone Min. Res. 21, 876-885.
192. Oshima, S., Onodera, S., Amizuka, N., Li, M., Irie, K., Watanabe, S., Koyama, Y., Nishihira, J., Yasuda, K. and Minami, A. (2006) Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett. 580, 1251-1256.
193. Ashcroft, G. S., Mills, S. J., Lei, K., Gibbons, L., Jeong, M. J., Taniguchi, M., Burow, M., Horan, M. A., Wahl, S. M. and Nakayama, T. (2003) Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 111, 1309-1318.
194. Onodera, S., Suzuki, K., Kaneda, K., Fujinaga, M. and Nishihira, J. (1999) Growth factor-induced expression of macrophage migration inhibitory factor in osteoblasts: relevance to the plasminogen activator system. Semin. Thromb. Hemost. 25, 563-568.
195. Onodera, S., Nishihira, J., Iwabuchi, K., Koyama, Y., Yoshida, K., Tanaka, S. and Minami, A. (2002) Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J. Biol. Chem. 277, 7865-7874.
196. Lee, S., Jacquin, C., Leng, L., Bucala, R. and Kuchel, G. (2006) Macrophage migration inhibitory factor is an inhibitor of osteoclastogenesis in vitro and in vivo. J. Bone. Min. Res. 21, S162.
197. Takeda, K. and Akira, S. (2004) TLR signaling pathways. Semin. Immunol. 16, 3-9.
198. Takami, M., Kim, N., Rho, J. and Choi, Y. (2002) Stimulation by toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169, 1516-1523.
199. Nair, S. P., Meghji, S., Wilson, M., Reddi, K., White, P. and Henderson, B. (1996) Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64, 2371-2380.
200. Kikuchi, T., Matsuguchi, T., Tsuboi, N., Mitani, A., Tanaka, S., Matsuoka, M., Yamamoto, G., Hishikawa, T., Noguchi, T. and Yoshikai, Y. (2001) Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166, 3574-3579.
201. Hayashi, S., Yamada, T., Tsuneto, M., Yamane, T., Takahashi, M., Shultz, L. D. and Yamazaki, H. (2003) Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J. Immunol. 171, 5130-5139.
202. Teng, Y. T., Nguyen, H., Gao, X., Kong, Y. Y., Gorczynski, R. M., Singh, B., Ellen, R. P. and Penninger, J. M. (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J. Clin. Invest. 106, R59-67.
203. Maruyama, K., Takada, Y., Ray, N., Kishimoto, Y., Penninger, J. M., Yasuda, H. and Matsuo, K. (2006) Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J. Immunol. 177, 3799-3805.
204. Li, H., Cuartas, E., Cui, W., Choi, Y., Crawford, T. D., Ke, H. Z., Kobayashi, K. S., Flavell, R. A. and Vignery, A. (2005) IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation. J. Exp. Med. 201, 1169-1177.